EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte Studie

Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke Units

Durch intravenöse Thrombolyse verhinderte Schlaganfälle: Sekundäranalyse einer prospektiven multizentrischen kontrollierten Studie zu Mobile Stroke Units

Babak B Navi iD, Ivo Bach, Alexandra L Czap, Mengxi Wang, Jose-Miguel Yamal, Asha P Jacob, Stephanie A Parker, Suja S Rajan iD, Saad Mir, Carla Sherman, Joshua Z Willey iD, Jeffrey L Saver und 21 weitere

Annals of Neurology · 2024-02 · 95 (2) · 347-361

DOI: 10.1002/ana.26816 ↗

Auf einen Blick

Bei 1.009 Patient:innen mit vermutetem Schlaganfall war eine mobile Stroke Unit mit häufigerem klinischem Erholen innerhalb von 24 Stunden verbunden. Auch ein bildgebend nicht nachweisbarer Schlaganfall trat häufiger auf.

Fragestellung

Wie häufig treten durch intravenöse Thrombolyse verhinderte Schlaganfälle in optimierten Schlaganfallversorgungssystemen auf, und unterscheidet sich dies zwischen Mobile Stroke Unit und Standardversorgung?

Methode

Sekundäranalyse einer multizentrischen Studie von 2014 bis 2020; Vergleich von MSU mit Standardversorgung bei Patient:innen mit vermutetem Schlaganfall und intravenöser Thrombolyse.

Ergebnisse

Unter 1.009 Patient:innen hatten 159 (16 %) einen tissue-definierten avierten Schlaganfall und 276 (27 %) einen Schlaganfall mit früher Symptombesserung. MSU: 18 % vs. 11 %, aOR 1,82 (95 %-KI 1,13–2,98) bzw. 31 % vs. 21 %, aOR 1,74 (95 %-KI 1,12–2,61).

Schlussfolgerung der Autor:innen

In optimierten Schlaganfallversorgungssystemen erholte sich 1 von 4 thrombolysierten Patient:innen innerhalb von 24 Stunden und 1 von 6 hatte keine im Bild nachweisbare Hirnschädigung.

Kernaussagen

  • 159 von 1.009 Patient:innen hatten einen tissue-definierten avierten Schlaganfall
  • MSU war mit mehr frühem klinischem Erholen verbunden
  • Jüngeres Alter, weibliches Geschlecht und niedrigere NIHSS waren assoziiert

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Neurology, online erschienen am 20.10.2023. Verfasst von Babak B Navi und 32 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New …. Hauptthemen laut MEDLINE: Stroke, Brain Ischemia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Patient-Centered Outcomes Research Institute.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study was undertaken to examine averted stroke in optimized stroke systems.

Methods

This secondary analysis of a multicenter trial from 2014 to 2020 compared patients treated by mobile stroke unit (MSU) versus standard management. The analytical cohort consisted of participants with suspected stroke treated with intravenous thrombolysis. The main outcome was a tissue‐defined averted stroke, defined as a final diagnosis of stroke with resolution of presenting symptoms/signs by 24 hours attributed to thrombolysis and no acute infarction/hemorrhage on imaging. An additional outcome was stroke with early symptom resolution, defined as a final diagnosis of stroke with resolution of presenting symptoms/signs by 24 hours attributed to thrombolysis.

Results

Among 1,009 patients with a median last known well to thrombolysis time of 87 minutes, 159 (16%) had tissue‐defined averted stroke and 276 (27%) had stroke with early symptom resolution. Compared with standard management, MSU care was associated with more tissue‐defined averted stroke (18% vs 11%, adjusted odds ratio [aOR] = 1.82, 95% confidence interval [CI] = 1.13–2.98) and stroke with early symptom resolution (31% vs 21%, aOR = 1.74, 95% CI = 1.12–2.61). The relationships between thrombolysis treatment time and averted/early recovered stroke appeared nonlinear. Most models indicated increased odds for stroke with early symptom resolution but not tissue‐defined averted stroke with earlier treatment. Additionally, younger age, female gender, hyperlipidemia, lower National Institutes of Health Stroke Scale, lower blood pressure, and no large vessel occlusion were associated with both tissue‐defined averted stroke and stroke with early symptom resolution.

Interpretation

In optimized stroke systems, 1 in 4 patients treated with thrombolysis recovered within 24 hours and 1 in 6 had no demonstrable brain injury on imaging. ANN NEUROL 2024;95:347–361

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeBrain IschemiaHumansFemaleTissue Plasminogen ActivatorFibrinolytic AgentsProspective StudiesHemorrhageThrombolytic TherapyTreatment Outcome

Substanzen

Tissue Plasminogen ActivatorFibrinolytic Agents

Autor:innen und Institutionen

  • Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, NY.
  • Department of Neurology, UTHealth McGovern Medical School, Houston, TX.
  • Department of Biostatistics and Data Science, UTHealth School of Public Health, Houston, TX.
  • Department of Neurology, Columbia University Irving Medical Center, New York, NY.
  • Department of Neurology, Ronald Reagan UCLA Medical Center, Los Angeles, CA.
  • Department of Neurology, University of Colorado, Aurora, CO.

ORCID-Profile: Babak B Navi, Suja S Rajan, Joshua Z Willey, Kelly Silnes

Förderung

  • Patient-Centered Outcomes Research Institute

Zitieren

APA

Navi, B. B., Bach, I., Czap, A. L., Wang, M., Yamal, J. M., Jacob, A. P., Parker, S. A., Rajan, S. S., Mir, S., Sherman, C., Willey, J. Z., Saver, J. L., Gonzalez, M. O., Singh, N., Jones, W. J., Ornelas, D., Gonzales, N. R., Alexandrov, A. W., Alexandrov, A. V., …, & Grotta, J. C. (2024). Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke Units. Annals of Neurology, 95(2), 347-361. https://doi.org/10.1002/ana.26816

Vancouver

Navi BB, Bach I, Czap AL, Wang M, Yamal JM, Jacob AP, et al. Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke Units. Annals of Neurology. 2024;95(2):347-361. doi:10.1002/ana.26816

BibTeX
@article{Navi2024,
  author = {Navi, Babak B and Bach, Ivo and Czap, Alexandra L and Wang, Mengxi and Yamal, Jose-Miguel and Jacob, Asha P and Parker, Stephanie A and Rajan, Suja S and Mir, Saad and Sherman, Carla and Willey, Joshua Z and Saver, Jeffrey L and Gonzalez, Michael O and Singh, Noopur and Jones, William J and Ornelas, David and Gonzales, Nicole R and Alexandrov, Anne W and Alexandrov, Andrei V and Nour, May and Spokoyny, Ilana and Mackey, Jason and Collins, Sarah Q and Silnes, Kelly and Fink, Mathew E and English, Joey and Barazangi, Nobl and Bratina, Patti L and Volpi, Jay and Rao, Chethan P V and Griffin, Laura and Persse, David and Grotta, James C},
  title = {Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke Units},
  journal = {Annals of Neurology},
  year = {2024},
  volume = {95},
  number = {2},
  pages = {347--361},
  doi = {10.1002/ana.26816}
}
Kostenlos starten →